Cordyceps Sunshine Biotech Holdings Co., Ltd. Deferred Income Tax Expense (Benefit)
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Deferred Income Tax Expense (Benefit) of -$42.22 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-07-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2024-07-05
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2023-12-31 | -$42.22K 20-F · filed 2024-07-05 |